Neutrophils process interleukin-1β and interleukin-18 precursors in a caspase-1-like fashion - Processing is inhibited by human vascular smooth muscle cells

European Cytokine Network

Volumn 17, Issue 1, 2006, Pages 19-28

  Westphal, Elena ^a   Herzberg, Mona ^b   Neumann, Ingo ^a   Beibei, Li ^a   Pilowski, Claudia ^a   Li, Chen ^a   Werdan, Karl ^a   Loppnow, Harald ^a,b  

^a MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

^b RESEARCH CENTER BORSTEL   (Germany)

Author keywords

Cytokines; Human; Inflammation; Monocytes Macrophages; Neutrophils

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 18; INTERLEUKIN 1BETA CONVERTING ENZYME; MESSENGER RNA; OLIGOPEPTIDE; PROTEIN PRECURSOR; TYROSYL VALYL ALANYL ASPARTAL; TYROSYL-VALYL-ALANYL-ASPARTAL;

ARTICLE; BIOSYNTHESIS; CELL COUNT; CELL CULTURE; DRUG ANTAGONISM; FIBROBLAST; GENETICS; HUMAN; METABOLISM; NEUTROPHIL; PHYSIOLOGY; PROTEIN PROCESSING; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

CASPASE 1; CELL COUNT; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; FIBROBLASTS; HUMANS; INTERLEUKIN-1; INTERLEUKIN-18; MUSCLE, SMOOTH, VASCULAR; NEUTROPHILS; OLIGOPEPTIDES; PROTEIN PRECURSORS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RNA, MESSENGER;

EID: 33746038596     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (79)

1. Libby P. Inflammation in atherosclerosis. Nature 2002; 420: 868.
2. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 352: 1685.
3. Dinarello CA. Biologic basis for interleukin-1 in disease. Blood 1996; 87: 2095.
4. Kirii H, Niwa T, Yamada Y, Wada H, Saito K, Iwakura Y, Asano M, Moriwaki H, Seishima M. Lack of interleukin-1β decreases the severity of atherosclerosis in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 2003; 23: 656.
5. Galea J, Armstrong J, Gadsdon P, Holden H, Francis SE, Holt CM. Interleukin-1β in coronary arteries of patients with ischemic heart disease. Arterioscler Thromb Vasc Biol 1996; 16: 1000.
6. Clinton SK, Fleet JC, Loppnow H, Salomon RN, Clark B, Cannon JG, Shaw AR, Dinarello CA, Libby P. Interleukin-1 gene expression in rabbit tissue in vivo. Am J Pathol 1991; 158: 1005.
7. Clausell N, Molossi S, Rabinovitch M. Increased interleukin-1β and fibronectin expression are early features of the development of the postcardiac transplant coronary arteriopathy in piglets. Am J Pathol 1993; 142: 1772.
8. Tanaka H, Sukhova G, Schwartz D, Libby P. Proliferating arterial smooth muscle cells after balloon injury express TNF-alpha but not interleukin-1 or basic fibroblast growth factor. Arterioscler Thromb Vasc Biol 1996; 16: 12.
9. Libby P, Ordovas JM, Birinyi LK, Auger KS, Dinarello CA. Inducible interleukin-1 gene expression in human vascular smooth muscle cells. J Clin Invest 1986; 78: 1432.
10. Loppnow H, Libby P. Functional significance of human vascular smooth muscle cell-derived interleukin-1 in paracrine and autocrine regulation pathways. Exp Cell Res 1992; 198: 283.
11. Cerretti DP, Kozlosky CJ, Mosley B, Nelson N, van Ness K, Greenstreet TA, March CC, Kronheim SR, Druck T, Cannizzaro LA, Huebner K, Black RA. Molecular cloning of the interleukin-1ß-converting enzyme. Science 1992; 256: 97.
12. Thornberry NA, Bull HG, Calaycay JR, Chapman KT, Howard AD, Kostura MJ, Miller DK, Molineaux SM, Weidner JR, Aunins J, Elliston KO, Ayala JM, Casano FJ, Chin J, Ding G-F, Egger LA, Gaffney EP, Limjuco G, Palyha OC, Raju SM, Rolando AM, Salley JP, Yamin TT, Lee TD, Shively JE, MacCross M, Mumford RA, Schmidt JA, Tocci MJ. A novel heterodimeric cysteine protease is required for interleukin-1β processing in monocytes. Nature 1992; 356: 768.
13. Kostura MJ, Tocci MJ, Limjuco G, Chin J, Cameron P, Hillman AG, Chartrain NA, Schmidt JA. Identification of a monocyte specific pre-interleukin-1ß convertase activity. Proc Natl Acad Sci USA 1989; 86: 5227.
14. Gu Y, Kuida K, Tsutsui H, Ku G, Hsiao K, Fleming MA, Hayashi N, Higashino K, Okamura H, Nakanishi K, Kurimoto M, Tanimoto T, Flavell RA, Sato V, Harding MW, Livingston DJ, Su MSS. Activation of interferon-γ-inducing factor mediated by interleukin-1β-converting enzyme. Science 1997; 275: 206.
15. Ghayur T, Banerjee S, Hugunin M, Butler D, Herzog L, Carter A, Quintal L, Sekut L, Talanian R, Paskind M, Wong W, Kamen R, Tracey D, Allen H. Caspase-1 processes IFN-γ-inducing factor and regulates LPS-induced IFN-γ production. Nature 1997; 386: 619.
16. Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McClanahan TK, Zurawski G, Moshrefi M, Qin J, Li X, Gorman DM, Bazan JF, Kastelein RA. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005; 23: 479.
17. Martinon F, Tschopp J. Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases. Cell 2004; 117: 561.
18. Derouet M, Thomas L, Moulding DA, Akgul C, Cross A, Moots RJ, Edwards SW. Sodium salicylate promotes neutrophil apoptosis by stimulating caspase-dependent turnover of Mcl-1. J Immunol 2006; 176: 957.
19. Watson RW, Rotstein OD, Parodo J, Jimenez M, Soric I, Bitar R, Marshall JC. Impaired apoptotic death signaling in inflammatory lung neutrophils is associated with decreased expression of interleukin-1β-converting enzyme family proteases (caspases). Surgery 1997; 122: 163.
20. Watson RW, Rotstein OD, Parodo J, Bitar R, Marshall JC. The IL-1β-converting enzyme (caspase-1) inhibits apoptosis of inflammatory neutrophils through activation of IL-1β. J Immunol 1998; 161: 957.
21. Kuida K, Lippke JA, Ku G, Harding MW, Livingston DJ, Su M-S, Flavell RA. Altered cytokine export and apoptosis in mice deficient in interleukin-1ß-converting enzyme. Science 1995; 267: 2000.
22. Miura M, Zhu H, Rotello R, Hartwieg EA, Yuan J. Induction of apoptosis in fibroblasts by IL-1β-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell 1993; 75: 653.
23. Guo H, Petrin D, Zhang Y, Bergeron C, Goodyer CG, LeBlanc AC. Caspase-1 activation of caspase-6 in human apoptotic neurons. Cell Death Differ 2006; 13: 285.
24. Feng Q, Li P, Salamanca C, Huntsman D, Leung PC, Auersperg N. Caspase-1α is down-regulated in human ovarian cancer cells and the overexpression of caspase-1α induces apoptosis. Cancer Res 2005; 65: 8591.
25. Zou H, Li Y, Liu X, Wang X. An APAF-1 cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J Biol Chem 1999; 274: 11549.
26. Tschopp J, Martinon F, Burns K. NALPs: a novel protein family involved in inflammation. Nat Rev Mol Cell Biol 2003; 4: 95.
27. Inohara N, Nunez G. NODs: intracellular proteins involved in inflammation and apoptosis. Nat Rev Immunol 2003; 3: 371.
28. Richards N, Schaner P, Diaz A, Stuckey J, Shelden E, Wadhwa A, Gumucio DL. Interaction between pyrin and the apoptotic speck protein (ASC) modulates ASC-induced apoptosis. J Biol Chem 2001; 276: 39320.
29. Shiohara M, Taniguchi S, Masumoto J, Yasui K, Koike K, Komiyama A, Sagara J. ASC, which is composed of a PYD and a CARD, is up-regulated by inflammation and apoptosis in human neutrophils. Biochem Biophys Res Commun 2002; 293: 1314.
30. Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 2006; 440: 237.
31. Mariathasan S, Newton K, Monack DM, Vucic D, French DM, Lee WP, Roose-Girma M, Erickson S, Dixit VM. Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 2004; 430: 213.
32. Evans HG, Lewis MJ, Shah AM. Interleukin-1β modulates myocardial contraction via dexamethasone sensitive production of nitric oxide. Cardiovasc Res 1993; 27: 1486.
33. Beasley D, Cohen RA, Levinsky NG. Interleukin-1 inhibits contraction of vascular smooth muscle. J Clin Invest 1989; 83: 331.
34. Geng Y-J, Wu Q, Muszinski M, Hansson G, Libby P. Apoptosis of vascular smooth muscle cells induced by in vitro stimulation with interferon-γ, tumor necrosis factor-α, and interleukin-1β. Arterioscler Thromb Vasc Biol 1996; 16: 19.
35. Englesbe MJ, Deou J, Bourns BD, Clowes AW, Daum G. Interleukin-1β inhibits PDGF-BB-induced migration by cooperating with PDGF-BB to induce cyclooxygenase-2 expression in baboon aortic smooth muscle cells. J Vasc Surg 2004; 39: 1091.
36. Li Z, Froehlich J, Galis ZS, Lakatta EG. Increased expression of matrix metalloproteinase-2 in the thickened intima of aged rats. Hypertension 1999; 33: 116.
37. Knipp BS, Ailawadi G, Ford JW, Peterson DA, Eagleton MJ, Roelofs KJ, Hannawa KK, Deogracias MP, Ji B, Logsdon C, Graziano KD, Simeone DM, Thompson RW, Henke PK, Stanley JC, Upchurch Jr. GR. Increased MMP-9 expression and activity by aortic smooth muscle cells after nitric oxide synthase inhibition is associated with increased nuclear factor-kappaB and activator protein-1 activity. J Surg Res 2004; 116: 70.
38. Hattori Y, Nakanishi N, Kasai K. Statin enhances cytokine-mediated induction of nitric oxide synthesis in vascular smooth muscle cells. Cardiovasc Res 2002; 54: 649.
39. Loppnow H, Westphal E, Buchhorn R, Wessel A, Werdan K. Interleukin-1 and related proteins in cardiovascular disease in adults and children. Shock 2001; 16(Supp 1): 3.
40. Loppnow H, Werdan K, Reuter G, Flad H-D. The interleukin-1 and interleukin-1-converting enzyme families in the cardiovascular system. Eur Cytokine Netw 1998; 9: 675.
41. Schönbeck U, Herzberg M, Petersen A, Wohlenberg C, Gerdes J, Flad H-D, Loppnow H. Human vascular smooth muscle cells express interleukin-1β-converting enzyme (ICE), but inhibit processing of the interleukin-1β precursor by ICE. J Exp Med 1997; 185: 1287.
42. Funayama H, Ikeda U, Takahashi M, Sakata Y, Kitagawa S, Takahashi Y, Masuyama J, Furukawa Y, Miura Y, Kano S, Matsuda M. K. S. Human monocyte-endothelial cell interaction induces platelet-derived growth factor expression. Cardiovasc Res 1998; 37: 216.
43. Nicklin MJH, Hughes DE, Barton JL, Ure JM, Duff GW. Arterial inflammation in mice lacking the interleukin-1 receptor antagonist gene. J Exp Med 2000; 191: 303.
44. Lord PC, Wilmoth LM, Mizel SB, McCall CE. Expression of interleukin-1α and β genes by human blood polymorphonuclear leukocytes. J Clin Invest 1991; 87: 1312.
45. Herzbeck H, Blum B, Rönspeck W, Frenzel B, Brandt E, Ulmer AJ, Flad H-D. Functional and molecular characterization of a monoclonal antibody against the 165-186 peptide of human IL-1β. Scand J Immunol 1989; 30: 549.
46. Loppnow H, Libby P. Proliferating or interleukin-1-activated human vascular smooth muscle cells secrete copious interleukin-6. J Clin Invest 1990; 85: 731.
47. Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest 1968; 21(Suppl. 97): 77.
48. Westphal E, Friedrich I, Silber RE, Werdan K, Loppnow H. Processing of interleukin-18 by human vascular smooth muscle cells. Adv Exp Med Biol 2000; 477: 343.
49. Schmidt JA, Mizel SB, Cohen D, Green I. Interleukin-1, a potential regulator of fibroblast proliferation. J Immunol 1982; 128: 2177.
50. Loppnow H, Flad H-D, Dürrbaum I, Musehold J, Fetting R, Ulmer AJ, Herzbeck H, Brandt E. Detection of interleukin-1 with human dermal fibroblasts. Immunobiology 1989; 179: 283.
51. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156.
52. Marucha PT, Zeff RA, Kreutzer DL. Cytokine regulation of IL-1β gene expression in the human polymorphonuclear leukocyte. J Immunol 1990; 145: 2932.
53. Nakahara H, Sato EF, Ishisaka R, Kanno T, Yoshioka T, Yasuda T, Inoue M, Utsumi K. Biochemical properties of human oral polymorphonuclear leukocytes. Free Rad Res 1998; 28: 485.
54. Black RA, Kronheim SR, Cantrell M, Deeley MC, March CJ, Prickett KS, Wignall J, Conlon PJ, Cosman D, Hopp TP, Mochizuki DY. Generation of biologically active interleukin-1β by proteolytic cleavage of the inactive precursor. J Biol Chem 1988; 263: 9437.
55. Hazuda DJ, Strickler J, Kueppers F, Simon PL, Young PR. Processing of precursor interleukin-1ß and inflammatory disease. J Biol Chem 1990; 265: 6318.
56. Mizutani H, Black R, Kupper TS. Human keratinocytes produce but do not process pro-interleukin-1ß. Different strategies of IL-1 production and processing in monocytes and keratinocytes. J Clin Invest 1991; 87: 1066.
57. Mosley BD, Dower SK, Gillis S, Cosman D. Determination of the minimum polypeptide lenghts of the functionally active sites of human interleukins-1α and -1β. Proc Natl Acad Sci USA 1987; 84: 4572.
58. Garcia-Calvo M, Peterson EP, Leiting B, Ruel R, Nicholson DW, Thornberry NA. Inhibition of human caspases by peptide-based and macromolecular inhibitors. J Biol Chem 1998; 273: 32608.
59. Tiku K, Tiku ML, Skosey JL. Interleukin-1 production by human polymorphonuclear neutrophils. J Immunol 1986; 136: 3677.
60. Bossu P, del Grosso E, Cesaroni MP, Maurizi G, Balestro N, Stoppacciaro A, del Giudice E, Ruggiero P, Boraschi D. Balance between autocrine interleukin-1β and caspases defines life versus death of polymorphonuclear cells. Eur Cytokine Netw 2001; 12: 177.
61. Rowe SJ, Allen L, Ridger VC, Hellewell PG, Whyte MK. Caspase-1-deficient mice have delayed neutrophil apoptosis and a prolonged inflammatory response to lipopolysaccharide-induced acute lung injury. J Immunol 2002; 169: 6401.
62. Re F, Mengozzi M, Muzio M, Dinarello CA, Mantovani A, Colotta F. Expression of interleukin-1 receptor antagonist (IL-1ra) by human circulating polymorphonuclear cells. Eur J Immunol 1993; 23: 570.
63. Suh B-C, Kim J-S, Namgung U, Ha H, Kim K-T. P2X7 nucleotide receptor mediation of membrane pore formation and superoxide generation in human promyelocytes and neutrophils. J Immunol 2001; 166: 6754.
64. Perregaux D, Gabel CA. Interleukin-1β maturation and release in response to ATP and nigericin. Evidence that potassium depletion mediated by these agents is a necessary and common feature of their activity. J Biol Chem 1994; 269: 15195.
65. Andrei C, Margiocco P, Poggi A, Lotti LV, Torrisi MR, Rubartelli A. Phospholipases C and A2 control lysosome-mediated IL-1β secretion: Implications for inflammatory processes. Proc Natl Acad Sci USA 2004; 101: 9745.
66. Elssner A, Duncan M, Gavrilin M, Wewers MD. A novel P2X7 receptor activator, the human cathelicidin-derived peptide LL37, induces IL-1 beta processing and release. J Immunol 2004; 172: 4987.
67. Kahlenberg JM, Lundberg KC, Kertesy SB, Qu Y, Dubyak GR. Potentiation of caspase-1 activation by the P2X7 receptor is dependent on TLR signals and requires NF-{kappa}B-driven protein synthesis. J Immunol 2005; 175: 7611.
68. Humke EW, Shriver SK, Starovasnik MA, Fairbrother WJ, Dixit VM. ICEBERG: A novel inhibitor of interleukin-1β generation. Cell 2000; 103: 99.
69. Annand RR, Dahlen JR, Sprecher CA, De Dreu P, Foster DC, Mankovich JA, Talanian RV, Kisiel W, Giegel DA. Caspase-1 (IL-1β-converting enzyme) is inhibited by the human serpin analogue proteinase inhibitor 9. Biochem J 1999; 342: 655.
70. Young JL, Sukhova GK, Foster D, Kisiel W, Libby P, Schönbeck U. The serpin proteinase inhibitor 9 is an endogenous inhibitor of IL-1β-converting enzyme (caspase-1) activity in human vascular smooth muscle cells. J Exp Med 2000; 191: 1535.
71. Chamaillard M, Girardin SE, Viala J, Philpott DJ. Nods, Nalps and Naip: intracellular regulators of bacterial-induced inflammation. Cell Microbiol 2003; 5: 581.
72. Shi Y. Caspase activation: revisiting the induced proximity model. Cell 2004; 117: 855.
73. Kollum M, Kaiser S, Kinscherf R, Metz J, Kubler W, Hehrlein C. Apoptosis after stent implantation compared with balloon angioplasty in rabbits. Role of macrophages. Arterioscler Thromb Vasc Biol 1997; 17: 2383.
74. Kockx MM, De Meyer GR, Bortier H, de Meyere N, Muhring J, Bakker A, Jacob W, Van Vaeck L, Herman A. Luminal foam cell accumulation is associated with smooth muscle cell death in the intimal thickening of human saphenous vein grafts. Circulation 1996; 94: 1255.
75. Geng Y-J, Libby P. Evidence for apoptosis in advanced human atheroma. Colocalization with ICE. Am J Path 1995; 147: 251.
76. Slim RM, Song Y, Albassam M, Dethloff LA. Apoptosis and nitrative stress associated with phosphodiesterase inhibitor-induced mesenteric vasculitis in rats. Toxicol Pathol 2003; 31: 638.
77. Donetti E, Baetta R, Comparato C, Altana C, Sartore S, Paoletti R, Castano P, Gabbiani G, Corsini A. Polymorphonuclear leukocytemyocyte interaction: an early event in collar-induced rabbit carotid intimal thickening. Exp Cell Res 2002; 274: 197.
78. Welt FG, Edelman ER, Simon DI, Rogers C. Neutrophil, not macrophage, infiltration precedes neointimal thickening in balloon-injured arteries. Arterioscler Thromb Vasc Biol 2000; 20: 2553.
79. Gonschior P, Gerheuser F, Gonschior GM, Maier GR, Mack B, Nerlich A, Lehr HA, Hofling B. Experimental directional atherectomy injury in arterial vessels: impact of trauma depth on cellular response. Am Heart J 1995; 129: 1067.